Global Contraceptive Gels Market Size By Type (Gels, Creams), By Application (Retail Stores, Drug Store), By Region, And Segment Forecasts, 2023 to 2032

The Global Contraceptive Gels Market was valued at USD 1.2 billion in 2023 and is projected to reach USD 2.1 billion by 2031, growing at a CAGR of 7.1% during the forecast period from 2023 to 2031. The market is driven by the rising awareness of non-hormonal birth control methods, increasing demand for women-centric contraceptive products, and growing concerns about hormonal side effects. Contraceptive gels provide a convenient, hormone-free, over-the-counter option that appeals to a broad demographic, particularly in developing markets where access to prescription methods is limited.

Drivers

Growing Preference for Non-Hormonal Options:

Many consumers are increasingly opting for non-hormonal contraceptive solutions due to concerns about the long-term side effects of hormonal treatments, such as mood swings, weight gain, and increased risk of cardiovascular issues. This preference significantly boosts the adoption of contraceptive gels.

Rising Female Autonomy in Reproductive Health:

The global shift toward empowering women to make independent decisions about reproductive health is fueling demand for accessible and self-administered contraceptive methods like gels.

Increased Availability and Regulatory Approvals:

Government initiatives and increasing regulatory support for over-the-counter contraceptive products are making gels more widely available, especially in North America and parts of Europe.

Restraints

Limited Awareness in Developing Countries:

Despite growing popularity in developed nations, many emerging markets still lack awareness and education on non-hormonal contraceptive alternatives, which hampers adoption.

Short-Term Efficacy and Reapplication Requirement:

Unlike long-term contraceptive methods, gels must be applied before each act of intercourse, which may reduce user compliance and affect overall market penetration.

Opportunity

Expansion in Emerging Economies:

Rising healthcare access and increasing public health awareness in regions like Asia-Pacific, Latin America, and parts of Africa present lucrative growth opportunities for manufacturers of contraceptive gels.

Product Innovations and Branding:

Ongoing R&D aimed at enhancing the efficacy, duration, and user experience of contraceptive gels is likely to attract a broader consumer base. Branding strategies emphasizing natural ingredients and ease of use are expected to further accelerate market expansion.

Market by System Type Insights

By system type, Nonoxynol-9-based gels held the largest market share in 2023, driven by longstanding market presence and proven spermicidal effectiveness. However, the plant-based and pH-regulating gel segment is anticipated to grow rapidly due to consumer inclination toward natural and chemical-free alternatives, especially in North America and Europe.

Market by End-use Insights

The retail pharmacy segment dominated the market in 2023, owing to the ease of availability and the increasing preference for over-the-counter contraceptive products. The online retail channel is projected to grow at the fastest rate during the forecast period, driven by the proliferation of e-commerce platforms and discreet purchase options.

Market by Regional Insights

In 2023, North America accounted for the largest share of the Global Contraceptive Gels Market, supported by high consumer awareness, favorable regulatory frameworks, and the presence of major players. Asia-Pacific is projected to register the fastest growth during the forecast period due to improving healthcare infrastructure, growing population, and rising focus on reproductive health education.

Competitive Scenario

Prominent players in the Global Contraceptive Gels Market include:

Evofem Biosciences, Inc.

Mayer Laboratories, Inc.

BioFilm Inc.

Cupid Limited

Reckitt Benckiser Group PLC

Church & Dwight Co., Inc.

These companies are investing in R&D, marketing strategies, and regional expansion to strengthen their market presence. For example:

In 2023, Evofem Biosciences launched a new formulation of its contraceptive gel product aimed at reducing vaginal irritation while maintaining efficacy.

In 2024, Mayer Laboratories expanded its distribution network across Southeast Asia, targeting underserved markets with education-driven marketing campaigns.

Scope of Work – Global Contraceptive Gels Market

Key Market Developments

2023: Evofem Biosciences received expanded FDA approval for a new variant of its contraceptive gel designed for prolonged use.

2024: Cupid Limited introduced a dual-function gel combining contraceptive and infection prevention properties in the Indian market.

2025: BioFilm Inc. launched a new range of eco-friendly packaged contraceptive gels to align with sustainability trends in consumer healthcare.

FAQs

1) What is the current market size of the Global Contraceptive Gels Market?

The market was valued at USD 1.2 billion in 2023.

2) What is the major growth driver of the Global Contraceptive Gels Market?

The major growth driver is the increasing preference for non-hormonal, over-the-counter contraceptive solutions.

3) Which is the largest region during the forecast period in the Global Contraceptive Gels Market?

North America remains the largest regional market due to high consumer awareness and regulatory support.

4) Which segment accounted for the largest market share in Global Contraceptive Gels Market?

The Nonoxynol-9-based gels segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Contraceptive Gels Market?

Key players include Evofem Biosciences, Mayer Laboratories, BioFilm Inc., Cupid Limited, and Reckitt Benckiser.